DEFA14A: Aemetis Seeks Shareholder Approval for Capital Structure Changes

Aemetis, Inc. is holding a Special Meeting on February 18, 2026, to vote on proposals to decrease authorized preferred stock and increase authorized common stock.

Summary

• A Special Meeting of Stockholders will be held on February 18, 2026, at 1:00 pm (Pacific Time) to consider three proposals.
• Proposal 1 seeks to amend the Certificate of Incorporation to decrease the number of authorized preferred stock shares from 65,000,000 to 5,000,000.
• Proposal 2 seeks to amend the Certificate of Incorporation to increase the number of authorized common stock shares from 80,000,000 to 140,000,000.
• Proposal 3 requests approval to adjourn the Special Meeting to a later date if insufficient votes are received for Proposal 1 or Proposal 2.
• The Board of Directors unanimously recommends that stockholders vote FOR all three proposals.
• As of the Record Date, December 24, 2025, approximately 66.2 million shares of common stock were outstanding, and no shares of preferred stock were outstanding.
• The fully diluted share count is approximately 76.8 million, leaving about 3.2 million common shares available for future issuance under the current authorization.
• The company is currently operating with negative cash flow and anticipates using its At-the-Market (ATM) stock offering to fund operational cash shortfalls and strategic initiatives.

Sentiment

Score: 6

Explanation: The proposals are necessary for the company's financial flexibility and growth, but the need for significant common stock authorization and reliance on ATM offerings due to negative cash flow indicates ongoing financial challenges and potential dilution for existing shareholders.

Positives

• Decreasing authorized preferred stock from 65,000,000 to 5,000,000 shares is considered good corporate housekeeping and may reduce Delaware franchise tax.
• Increasing authorized common stock from 80,000,000 to 140,000,000 shares provides necessary flexibility to finance operations and future growth.
• A sufficient share reserve is essential for the company's ability to raise capital and invest in business expansion and strategic initiatives.
• The ability to offer competitive equity compensation helps attract and retain top talent critical to the company's success.
• Maintaining financial and strategic flexibility allows the Board to act decisively on opportunities without the delay and expense of seeking stockholder approval for each instance.

Negatives

• The issuance of additional shares of common stock, including through the ATM program and equity compensation plans, will dilute the equity interest of current stockholders.
• Dilution would reduce current stockholders' relative voting power and could reduce earnings per share.
• The sale of a substantial number of common shares, or the perception of such sales, could adversely affect the prevailing market price of the common stock.
• Increasing the number of authorized common shares without a corresponding decrease in preferred shares could result in a higher annual Delaware franchise tax.
• Institutional investors and proxy advisory firms carefully review proposals to increase authorized shares and scrutinize the size and dilutive impact of equity compensation plans.

Risks

• Dilution of current stockholders' equity interest due to the issuance of additional common stock.
• Potential adverse impact on the market price of common stock from substantial sales or the perception of such sales.
• Increased annual Delaware franchise tax if the increase in authorized common stock is not fully offset by the decrease in authorized preferred stock.
• Ongoing negative cash flow necessitates reliance on capital raises, such as the At-the-Market (ATM) stock offering, which contributes to dilution.
• Future grants under equity compensation plans will contribute to dilution for existing stockholders.

Future Outlook

The company anticipates using its At-the-Market (ATM) stock offering to continue funding operational cash shortfalls as it executes its strategic plan. Funds will also be used to invest in business expansion and other strategic initiatives aimed at driving long-term growth. The proposed increase in authorized common stock is viewed as a critical step to ensure resources for operations and strategic growth plans.

Management Comments

• "The Board believes that the current number of authorized Preferred Shares is significantly higher than what is needed for the foreseeable future."
• "This proposal is a matter of good corporate housekeeping intended to align the number of authorized Preferred Shares more closely with the Company's current and anticipated needs."
• "The Board believes that approving this proposal [Increase of Authorized Common Stock] is a critical step to ensure the Company has the resources to fund operations, pursue its strategic growth plans, and enhance stockholder value."
• "The Company is currently operating with negative cash flow, and we anticipate using our At-the-Market (ATM) stock offering to continue funding operational cash shortfalls as we execute our strategic plan."
• "To retain and compete for talented employees who are critical to our success, we must be able to offer competitive equity compensation."
• "The Board, however, does not intend or view this authorized share increase proposal as an anti-takeover measure, nor does the Board propose this amendment with any anti-takeover purpose in mind."

Industry Context

This filing reflects a common practice among growth-oriented companies, particularly those with negative cash flow, to ensure sufficient capital-raising flexibility and to maintain competitive employee compensation through equity. The need for increased authorized shares for funding operations and strategic growth is typical for companies in expansion phases or those requiring ongoing investment in research and development or infrastructure.

Comparison to Industry Standards

• NA

Corporate Governance

Related Party Transactions

• Directors and executive officers have an interest in Proposal 2 (Increase of Authorized Common Stock) to the extent that it ensures a sufficient number of shares are available for issuance under existing equity incentive plans, potentially leading to future equity-based awards.

Stakeholder Impact

• Shareholders: Face potential dilution of their equity interest, reduced voting power, and possible adverse effects on common stock market price due to future share issuances. However, the proposals aim to support long-term growth and value creation.
• Employees: Benefit from the company's enhanced ability to attract and retain top talent through competitive equity compensation plans, aligning their interests with stockholders.
• Creditors: The increased financial flexibility from potential capital raises could improve the company's ability to fund operations and strategic initiatives, potentially strengthening its financial position over time, but reliance on equity raises due to negative cash flow indicates ongoing financial strain.

Next Steps

• Stockholders will vote on the proposed amendments to the Certificate of Incorporation and the Adjournment Proposal at the Special Meeting on February 18, 2026.
• If approved, the company will proceed with amending its Certificate of Incorporation to adjust authorized share counts.
• The company plans to continue utilizing its At-the-Market (ATM) stock offering to fund operations and strategic initiatives.
• The company intends to invest in business expansion and other strategic initiatives to drive long-term growth.

Key Dates

Recommendation

The proposals are crucial for Aemetis to maintain financial flexibility and fund its operations and growth, especially given its negative cash flow. While the increase in authorized common stock is necessary, it also signals potential significant dilution for existing shareholders through future ATM offerings and equity compensation. Investors should hold to monitor the execution of strategic plans and the impact of future capital raises on share price and ownership, weighing the necessity of these actions against the dilutive effects.

Keywords

Aemetis, common stock, preferred stock, authorized shares, capital structure, dilution, corporate governance, proxy statement, special meeting, equity compensation, ATM offering, SEC filing, DEFA14A